BeiGene Valuation
| BGNE Stock | USD 206.16 14.05 7.31% |
At this time, the firm appears to be undervalued. BeiGene shows a prevailing Real Value of $234.02 per share. The current price of the firm is $206.16. Our model approximates the value of BeiGene from analyzing the firm fundamentals such as Return On Equity of -0.23, profit margin of (0.26) %, and Current Valuation of 19.6 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting BeiGene's valuation include:
Price Book 5.961 | Enterprise Value 19.6 B | Enterprise Value Ebitda (11.91) | Price Sales 0.9017 | Forward PE 384.6154 |
Undervalued
Today
Please note that BeiGene's price fluctuation is very steady at this time. Calculation of the real value of BeiGene is based on 3 months time horizon. Increasing BeiGene's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BeiGene stock is determined by what a typical buyer is willing to pay for full or partial control of BeiGene. Since BeiGene is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BeiGene Stock. However, BeiGene's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 206.16 | Real 234.02 | Target 292.53 | Hype 205.98 | Naive 197.39 |
The real value of BeiGene Stock, also known as its intrinsic value, is the underlying worth of BeiGene Company, which is reflected in its stock price. It is based on BeiGene's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BeiGene's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BeiGene helps investors to forecast how BeiGene stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BeiGene more accurately as focusing exclusively on BeiGene's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use BeiGene's intrinsic value based on its ongoing forecasts of BeiGene's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against BeiGene's closest peers. If more than one evaluation category is relevant for BeiGene we suggest using both methods to arrive at a better estimate.
BeiGene Cash |
|
BeiGene Valuation Trend
Comparing BeiGene's enterprise value against its market capitalization is a good way to estimate the value of BeiGene uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
BeiGene Revenue by Product
BeiGene Total Value Analysis
BeiGene is currently estimated to have valuation of 19.6 B with market capitalization of 21.2 B, debt of 930.18 M, and cash on hands of 5.7 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BeiGene fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
19.6 B | 21.2 B | 930.18 M | 5.7 B |
BeiGene Investor Information
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 8.18. BeiGene had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from BeiGene's historical financial statements, BeiGene is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.BeiGene Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BeiGene has an asset utilization ratio of 42.35 percent. This indicates that the Company is making $0.42 for each dollar of assets. An increasing asset utilization means that BeiGene is more efficient with each dollar of assets it utilizes for everyday operations.BeiGene Ownership Allocation
BeiGene holds a total of 97.77 Million outstanding shares. 30% of BeiGene outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BeiGene Profitability Analysis
The company reported the previous year's revenue of 2.46 B. Net Loss for the year was (881.71 M) with loss before overhead, payroll, taxes, and interest of (511.06 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BeiGene's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BeiGene and how it compares across the competition.
About BeiGene Valuation
The stock valuation mechanism determines BeiGene's current worth on a weekly basis. Our valuation model uses a comparative analysis of BeiGene. We calculate exposure to BeiGene's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BeiGene's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.1 B | 2.2 B | |
| Pretax Profit Margin | (0.34) | (0.35) | |
| Operating Profit Margin | (0.49) | (0.52) | |
| Net Loss | (0.36) | (0.38) | |
| Gross Profit Margin | 0.85 | 0.89 |
BeiGene Growth Indicators
Investing in growth stocks can be very risky. If the company such as BeiGene does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 104.4 M | |
| Forward Price Earnings | 384.6154 |
BeiGene Current Valuation Indicators
Valuation refers to the process of determining the present value of BeiGene and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value BeiGene we look at many different elements of the entity such as BeiGene's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as BeiGene, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use BeiGene's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes BeiGene's worth.Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |